REFERENCES
1. De Koning C, Plantinga M, Besseling P, Boelens JJ, Nierkens S. Immune
Reconstitution after Allogeneic Hematopoietic Cell Transplantation in
Children. Biol Blood Marrow Transplant . 2016;22:195-206.
doi:10.1016/j.bbmt.2015.08.028
2. Dekker L, de Koning C, Lindemans C, Nierkens S. Reconstitution of t
cell subsets following allogeneic hematopoietic cell transplantation.Cancers . 2020;12(7):1-21. doi:10.3390/cancers12071974
3. Storek J, Geddes M, Khan F, et al. Reconstitution of the immune
system after hematopoietic stem cell transplantation in humans.Semin Immunopathol . 2008;30(4):425-437.
doi:10.1007/s00281-008-0132-5
4. Forcina A, Noviello M, Carbone MR, Bonini C, Bondanza A. Predicting
the Clinical Outcome of Allogeneic Hematopoietic Stem Cell
Transplantation: The Long and Winding Road toward Validated Immune
Biomarkers. Front Immunol . 2013;4:71.
doi:10.3389/fimmu.2013.00071
5. Ogonek J, Juric MK, Ghimire S, et al. Immune reconstitution after
allogeneic hematopoietic stem cell transplantation. Front
Immunol . 2016;7(NOV):1-15. doi:10.3389/fimmu.2016.00507
6. De Vries E, Van Tol MJD, Langlois Van Den Bergh R, et al.
Reconstitution of lymphocyte subpopulations after paediatric bone marrow
transplantation. Bone Marrow Transplant . 2000;25(3):267-275.
doi:10.1038/sj.bmt.1702141
7. Kalwak K, Gorczynska E, Toporski J, et al. Immune reconstitution
after haematopoietic cell transplantation in children: immunophenotype
analysis with regard to factors affecting the speed of recovery.Br J Haematol . 2002;118(1):74-89.
doi:10.1046/j.1365-2141.2002.03560.x
8. Geddes M, Storek J. Immune reconstitution following hematopoietic
stem-cell transplantation. Best Pract Res Clin Haematol .
2007;20(2):329-348. doi:10.1016/j.beha.2006.09.009
9. Gale RP, Seber A, Bonfim C, Pasquini M. Haematopoietic cell
transplants in Latin America. Bone Marrow Transplant .
2016;51(7):898-905. doi:10.1038/bmt.2016.35
10. Bayraktar UD, Milton DR, Guindani M, et al. Optimal Threshold and
Time of Absolute Lymphocyte Count Assessment for Outcome Prediction
after Bone Marrow Transplantation. Biol Blood Marrow Transplant .
2016;22(3):505-513. doi:10.1016/j.bbmt.2015.10.020
11. Rigoni L, Scroferneker ML, Pitombeira BS, et al. Importance of early
absolute lymphocyte count after allogeneic stem cell transplantation: A
retrospective study. Transplant Proc . 2015;47(2):511-516.
doi:10.1016/j.transproceed.2014.11.042
12. Yamamoto W, Ogusa E, Matsumoto K, Maruta A, Ishigatsubo Y, Kanamori
H. Lymphocyte recovery on day 100 after allogeneic hematopoietic stem
cell transplant predicts non-relapse mortality in patients with acute
leukemia or myelodysplastic syndrome. Leuk Lymphoma .
2014;55(5):1113-1118. doi:10.3109/10428194.2013.823491
13. Bühlmann L, Buser AS, Cantoni N, et al. Lymphocyte subset recovery
and outcome after T-cell replete allogeneic hematopoietic SCT.Bone Marrow Transplant . 2011;46(10):1357-1362.
doi:10.1038/bmt.2010.306
14. Bae KW, Kim BE, Koh KN, Im HJ, Seo JJ. Factors influencing
lymphocyte reconstitution after allogeneic hematopoietic stem cell
transplantation in children. Korean J Hematol . 2012;47(1):44-52.
doi:10.5045/kjh.2012.47.1.44
15. Kanate AS, Nagler A, Savani B. Summary of Scientific and Statistical
Methods, Study Endpoints and Definitions for Observational and
Registry-Based Studies in Hematopoietic Cell Transplantation. Clin
Hematol Int . 2019;2(1):2-4. doi:10.2991/chi.d.191207.001
16. 1994 Consensus Conference on Acute GVHD Grading. - PubMed - NCBI.
https://www.ncbi.nlm.nih.gov/pubmed/7581076. Published 1995. Accessed
May 15, 2020.
17. Le Blanc K, Barrett AJ, Schaffer M, et al. Lymphocyte recovery is a
major determinant of outcome after matched unrelated myeloablative
transplantation for myelogenous malignancies. Biol Blood Marrow
Transplant . 2009;15(9):1108-1115. doi:10.1016/j.bbmt.2009.05.015
18. Kim HO, Oh HJ, Lee JW, et al. Immune reconstitution after allogeneic
hematopoietic stem cell transplantation in children: A single
institution study of 59 patients. Korean J Pediatr .
2013;56(1):26-31. doi:10.3345/kjp.2013.56.1.26
19. Bartelink IH, Belitser S V., Knibbe CAJ, et al. Immune
Reconstitution Kinetics as an Early Predictor for Mortality using
Various Hematopoietic Stem Cell Sources in Children. Biol Blood
Marrow Transplant . 2013;19(2):305-313. doi:10.1016/j.bbmt.2012.10.010
20. Storek J. Immunological reconstitution after hematopoietic cell
transplantation - Its relation to the contents of the graft.Expert Opin Biol Ther . 2008;8(5):583-597.
doi:10.1517/14712598.8.5.583
21. Thapa P, Farber DL. The Role of the Thymus in the Immune Response.Thorac Surg Clin . 2019;29(2):123-131.
doi:10.1016/j.thorsurg.2018.12.001
22. Williams KM, Gress RE. Immune reconstitution and implications for
immunotherapy following haematopoietic stem cell transplantation.Best Pract Res Clin Haematol . 2008;21(3):579-596.
doi:10.1016/j.beha.2008.06.003
23. Kuball J, Boelens JJ. Clinical and biological concepts for mastering
immune reconstitution after HSCT: toward practical guidelines and
greater harmonization. In: Carreras E, et al, eds. The EBMT
Handbook . Springer, Cham; 2019:69-74.
24. Körbling M, Anderlini P. Peripheral blood stem cell versus bone
marrow allotransplantation: Does the source of hematopoietic stem cells
matter? Blood . 2001;98(10):2900-2908.
doi:10.1182/blood.V98.10.2900
25. Storek J, Dawson MA, Storer B, et al. Immune reconstitution after
allogeneic marrow transplantation compared with blood stem cell
transplantation. Blood . 2001;97(11):3380-3389.
doi:10.1182/blood.V97.11.3380
26. Fedele R, Martino M, Garreffa C, et al. The impact of early CD4+
lymphocyte recovery on the outcome of patients who undergo allogeneic
bone marrow or peripheral blood stem cell transplantation. Blood
Transfus . 2012;10(2):174-180. doi:10.2450/2012.0034-11
27. Admiraal R, van Kesteren C, Jol-van der Zijde CM, et al. Association
between anti-thymocyte globulin exposure and CD4+ immune reconstitution
in paediatric haemopoietic cell transplantation: a multicentre,
retrospective pharmacodynamic cohort analysis. Lancet Haematol .
2015;2(5):e194-e203. doi:10.1016/S2352-3026(15)00045-9
28. Reddehase MJ. Mutual interference between cytomegalovirus and
reconstitution of protective immunity after hematopoietic cell
transplantation. Front Immunol . 2016;7.
doi:10.3389/fimmu.2016.00294
29. Alexandersson A, Koskenvuo M, Tiderman A, et al. Viral infections
and immune reconstitution interaction after pediatric allogenic
hematopoietic stem cell transplantation. Infect Dis .
2019;51(10):772-778. doi:10.1080/23744235.2019.1650198
30. Janeczko M, Mielcarek M, Rybka B, Ryczan-Krawczyk R,
Noworolska-Sauren D, Kałwak K. Immune recovery and the risk of CMV/ EBV
reactivation in children post allogeneic haematopoietic stem cell
transplantation. Cent Eur J Immunol . 2016;41(3):287-296.
doi:10.5114/ceji.2016.63129
31. Drylewicz J, Schellens IMM, Gaiser R, et al. Rapid reconstitution of
CD4 T cells and NK cells protects against CMV-reactivation after
allogeneic stem cell transplantation. J Transl Med .
2016;14(1):230. doi:10.1186/s12967-016-0988-4
32. Suessmuth Y, Mukherjee R, Watkins B, et al. CMV reactivation drives
posttransplant T-cell reconstitution and results in defects in the
underlying TCRβ repertoire. Blood . 2015;125(25):3835-3850.
doi:10.1182/blood-2015-03-631853
33. Berger M, Figari O, Bruno B, et al. Lymphocyte subsets recovery
following allogeneic bone marrow transplantation (BMT): CD4+ cell count
and transplant-related mortality. Bone Marrow Transplant .
2008;41(1):55-62. doi:10.1038/sj.bmt.1705870
34. Clave E, Busson M, Douay C, et al. Acute graft-versus-host disease
transiently impairs thymic output in young patients after allogeneic
hematopoietic stem cell transplantation. Blood .
2009;113(25):6477-6484. doi:10.1182/blood-2008-09-176594
35. Dudakov JA, Perales MA, van den Brink MRM. Immune reconstitution
following hematopoietic cell transplantation. In: Forman SJ, et al, eds.Thomas’ Hematopoietic Cell Transplantation, 5th ed. Wiley
Blackwell; 2016:160-169. doi:10.1002/9781118416426.ch15
36. Luznik L, Fuchs EJ. High-dose, post-transplantation cyclophosphamide
to promote graft-host tolerance after allogeneic hematopoietic stem cell
transplantation. Immunol Res . 2010;47(1-3):65-77.
doi:10.1007/s12026-009-8139-0
37. McCurdy SR, Vulic A, Symons HJ, et al. Comparable and Robust Immune
Reconstitution after HLA-Haploidentical or HLA-Matched Allogeneic
Transplantation (BMT) Utilizing Posttransplantation Cyclophosphamide.Biol Blood Marrow Transplant . 2015;21(2):S71.
doi:10.1016/j.bbmt.2014.11.075
38. Lin CH, Su YJ, Hsu CY, Wang PN, Teng CLJ. Haploidentical allogeneic
hematopoietic stem cell transplantation increases the risk of
cytomegalovirus infection in adult patients with acute leukemia.Transpl Infect Dis . 2019;21(4). doi:10.1111/tid.13096
39. Bashey A, Zhang X, Jackson K, et al. Comparison of Outcomes of
Hematopoietic Cell Transplants from T-Replete Haploidentical Donors
Using Post-Transplantation Cyclophosphamide with 10 of 10 HLA-A, -B, -C,
-DRB1, and -DQB1 Allele-Matched Unrelated Donors and HLA-Identical
Sibling Donors: A Multivariable Analysis Including Disease Risk Index.Biol Blood Marrow Transplant . 2016;22(1):125-133.
doi:10.1016/j.bbmt.2015.09.002
40. Kim DH, Sohn SK, Won DI, Lee NY, Suh JS, Lee KB. Rapid helper T-cell
recovery above 200 x 10 6/l at 3 months correlates to successful
transplant outcomes after allogeneic stem cell transplantation.Bone Marrow Transplant . 2006;37(12):1119-1128.
doi:10.1038/sj.bmt.1705381